US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
from NDTV News - Latest https://ift.tt/31iRNjC
Wednesday, December 1, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment